Evidence map›Paper›PMID 36040167›Full record

ArticleBioinformatics (Oxford, England)2022

Tangent normalization for somatic copy-number inference in cancer genome analysis.

Galen F Gao, Coyin Oh, Gordon Saksena, Davy Deng, Lindsay C Westlake, Barbara A Hill, Michael Reich, Steven E Schumacher, Ashton C Berger, Scott L Carter and 5 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Galen F GaoCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-3143-9270
Coyin OhCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-5732-3471
Gordon SaksenaCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Davy DengCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Lindsay C WestlakeCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Barbara A HillCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Michael ReichCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Steven E SchumacherCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Ashton C BergerCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Scott L CarterCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Andrew D CherniackCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Matthew MeyersonCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Barbara TabakCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Rameen BeroukhimCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Gad GetzCancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-0936-0753

Funding

Genome Characterization Center (GCC)U24CA143867 · NCI · BROAD INSTITUTE, INC. · PI GABRIEL, STACEY, MEYERSON, MATTHEW L. · 2009 to 2016
$17.0M
The Cancer Genome Atlas Data Analysis CenterU24CA143845 · NCI · BROAD INSTITUTE, INC. · PI CHIN, LYNDA, GETZ, GAD A · 2009 to 2016
$16.0M
The Cell-Of-Origin of Human CancersU54CA143798 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI MICHOR, FRANZISKA · 2009 to 2014
$11.2M
Center for Cancer Genome CharacterizationU24CA126546 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MEYERSON, MATTHEW L. · 2006 to 2009
$7.7M
Genetic evolution of glioblastomas during radiation and temozolomide therapyR01CA188228 · NCI · DANA-FARBER CANCER INST · PI BEROUKHIM, RAMEEN, CHAKRAVARTI, ARNAB · 2015 to 2025
$6.9M
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine GliomasR01CA219943 · NCI · BROAD INSTITUTE, INC. · PI BEROUKHIM, RAMEEN, LIGON, KEITH LLOYD · 2017 to 2021
$2.5M
Center for the Comprehensive Analysis of Cancer Somatic Copy-Number Alterations, Rearrangements, and Long-Read Sequencing DataU24CA264029 · NCI · BROAD INSTITUTE, INC. · PI BEROUKHIM, RAMEEN, CHERNIACK, ANDREW DAVID · 2021 to 2025
$1.9M
NCI NIH HHS R01 CA188228NCI NIH HHS R01 CA219943NCI NIH HHS U24 CA126546NCI NIH HHS U24 CA143845NCI NIH HHS U24 CA143867NCI NIH HHS U24 CA264029NCI NIH HHS U54 CA143798NIH HHS U24CA126546
6 · The paper itself

Abstract

motivationSomatic copy-number alterations (SCNAs) play an important role in cancer development. Systematic noise in sequencing and array data present a significant challenge to the inference of SCNAs for cancer genome analyses. As part of The Cancer Genome Atlas, the Broad Institute Genome Characterization Center developed the Tangent normalization method to generate copy-number profiles using data from single-nucleotide polymorphism (SNP) arrays and whole-exome sequencing (WES) technologies for over 10 000 pairs of tumors and matched normal samples. Here, we describe the Tangent method, which uses a unique linear combination of normal samples as a reference for each tumor sample, to subtract systematic errors that vary across samples. We also describe a modification of Tangent, called Pseudo-Tangent, which enables denoising through comparisons between tumor profiles when few normal samples are available.

resultsTangent normalization substantially increases signal-to-noise ratios (SNRs) compared to conventional normalization methods in both SNP array and WES analyses. Tangent and Pseudo-Tangent normalizations improve the SNR by reducing noise with minimal effect on signal and exceed the contribution of other steps in the analysis such as choice of segmentation algorithm. Tangent and Pseudo-Tangent are broadly applicable and enable more accurate inference of SCNAs from DNA sequencing and array data. AVAILABILITY AND IMPLEMENTATION: Tangent is available at https://github.com/broadinstitute/tangent and as a Docker image (https://hub.docker.com/r/broadinstitute/tangent). Tangent is also the normalization method for the copy-number pipeline in Genome Analysis Toolkit 4 (GATK4). SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

NeoplasmsSoftwareAlgorithmsDNA Copy Number VariationsHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID36040167
PMCPMC9563697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.